Lars Magne Eri

1.4k total citations
38 papers, 1.0k citations indexed

About

Lars Magne Eri is a scholar working on Pulmonary and Respiratory Medicine, Urology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lars Magne Eri has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 19 papers in Urology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lars Magne Eri's work include Prostate Cancer Diagnosis and Treatment (21 papers), Urinary Bladder and Prostate Research (17 papers) and Hormonal and reproductive studies (12 papers). Lars Magne Eri is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (21 papers), Urinary Bladder and Prostate Research (17 papers) and Hormonal and reproductive studies (12 papers). Lars Magne Eri collaborates with scholars based in Norway, Germany and Sweden. Lars Magne Eri's co-authors include Kjell J. Tveter, Aud Svindland, Erik Rud, Eduard Baco, Heidi B. Eggesbø, Petter Urdal, Viktor Berge, Ljiljana Vlatkovic, Osamu Ukimura and Gunnar Moen and has published in prestigious journals such as The Lancet Oncology, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Lars Magne Eri

38 papers receiving 998 citations

Peers

Lars Magne Eri
Ramiro Castro United States
J. Blom Netherlands
Arcangelo Sebastianelli Italy
Matteo Salvi Italy
Álvaro Páez Spain
İlker Tınay Türkiye
Justin R. Gregg United States
Zhao-Dian Chen China
Nobufumi Ueda Japan
Shengqiang Yu China
Ramiro Castro United States
Lars Magne Eri
Citations per year, relative to Lars Magne Eri Lars Magne Eri (= 1×) peers Ramiro Castro

Countries citing papers authored by Lars Magne Eri

Since Specialization
Citations

This map shows the geographic impact of Lars Magne Eri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Magne Eri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Magne Eri more than expected).

Fields of papers citing papers by Lars Magne Eri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Magne Eri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Magne Eri. The network helps show where Lars Magne Eri may publish in the future.

Co-authorship network of co-authors of Lars Magne Eri

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Magne Eri. A scholar is included among the top collaborators of Lars Magne Eri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Magne Eri. Lars Magne Eri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guldvik, Ingrid Jenny, Håkon Ramberg, Gitte Kristensen, et al.. (2022). Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer. European Urology Open Science. 45. 68–75. 2 indexed citations
2.
Giskeødegård, Guro F., Elise Sandsmark, Helena Bertilsson, et al.. (2017). Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy. British Journal of Cancer. 117(11). 1656–1664. 36 indexed citations
3.
Paur, Ingvild, Wolfgang Lilleby, Siv Kjølsrud Bøhn, et al.. (2016). Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA. Clinical Nutrition. 36(3). 672–679. 56 indexed citations
4.
Idland, Ane‐Victoria, Torgeir Bruun Wyller, Randi Støen, et al.. (2016). Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium. Journal of Alzheimer s Disease. 55(1). 371–379. 45 indexed citations
5.
Fosså, Sophie D., et al.. (2016). Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26). Scandinavian Journal of Urology. 50(4). 280–285. 16 indexed citations
6.
Rud, Erik, Eduard Baco, Dagmar Klotz, et al.. (2015). Does Preoperative Magnetic Resonance Imaging Reduce the Rate of Positive Surgical Margins at Radical Prostatectomy in a Randomised Clinical Trial?. European Urology. 68(3). 487–496. 44 indexed citations
7.
8.
Rud, Erik, Dagmar Klotz, Eduard Baco, et al.. (2014). Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer. World Journal of Urology. 33(7). 1015–1021. 18 indexed citations
9.
Siddiqui, Huma, Karin Lagesen, Alexander J. Nederbragt, et al.. (2014). Pathogens in Urine from a Female Patient with Overactive Bladder Syndrome Detected by Culture-independent High Throughput Sequencing: A Case Report. The Open Microbiology Journal. 8(1). 148–153. 15 indexed citations
10.
11.
Axcrona, Karol, Anders Angelsen, Christian Beisland, et al.. (2012). Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? - Findings from a prospective national study. Scandinavian Journal of Urology. 47(2). 92–100. 21 indexed citations
12.
13.
Berge, Viktor, et al.. (2011). Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer. Scandinavian Journal of Urology and Nephrology. 46(1). 8–13. 7 indexed citations
14.
Eri, Lars Magne, et al.. (2002). Comparative study of pressure‐flow parameters. Neurourology and Urodynamics. 21(3). 186–193. 12 indexed citations
15.
Fosså, Sophie D., Lars Magne Eri, Eva Skovlund, Kjell J. Tveter, & Lars J. Vatten. (2001). No randomised trial of prostatecancer screening in Norway. The Lancet Oncology. 2(12). 741–745. 11 indexed citations
16.
Eri, Lars Magne & Aud Svindland. (2000). Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?. Urology. 56(2). 261–265. 5 indexed citations
17.
Eri, Lars Magne & Kjell J. Tveter. (1997). Treatment of Benign Prostatic Hyperplasia. Drugs & Aging. 10(2). 107–118. 14 indexed citations
18.
19.
Tveter, Kjell J. & Lars Magne Eri. (1994). Safety, Side Effects andPatient Acceptance of theAntiandrogen Casodex in theTreatment of Benign ProstaticHyperplasia. European Urology. 26(3). 219–226. 14 indexed citations
20.
Eri, Lars Magne, et al.. (1988). Pseudocyst of the spleen after closed abdominal injury. Injury. 19(4). 297–297. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramiro Castro Breakdown of academic impact, for papers by J. Blom Breakdown of academic impact, for papers by Arcangelo Sebastianelli Breakdown of academic impact, for papers by Matteo Salvi Breakdown of academic impact, for papers by Álvaro Páez Breakdown of academic impact, for papers by İlker Tınay Breakdown of academic impact, for papers by Justin R. Gregg Breakdown of academic impact, for papers by Zhao-Dian Chen Breakdown of academic impact, for papers by Nobufumi Ueda Breakdown of academic impact, for papers by Shengqiang Yu
Rankless by CCL
2026